Search results for "Htert mrna"

showing 2 items of 2 documents

Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in the Plasma of Patients with Prostate Cancer

2006

The aim of this study was to evaluate the potential diagnostic value of quantitative analysis of human telomerase reverse transcriptase (hTERT) mRNA in plasma for noninvasive diagnosis of prostate cancer (PCa). Expression levels of hTERT were analyzed by real-time quantitative RT-PCR in 68 patients showing elevated prostate-specific antigen (PSA) levels and a control group of 44 healthy volunteers. Sensitivity and specificity were determined and compared to the corresponding PSA values. Median values for hTERT gene expression in the PCa patients (0.72 ng; range 0.01-12.86) were statistically significantly higher (P < 0.001) than in the control group (0.13 ng; 0.02-0.35). Patients with clini…

MaleOncologyPathologymedicine.medical_specialtyStatistics as TopicProstatitisGeneral Biochemistry Genetics and Molecular BiologyPlasmaProstate cancerHistory and Philosophy of ScienceAntigenProstateInternal medicinemedicineHumansTelomerase reverse transcriptaseRNA MessengerTelomeraseMessenger RNAReverse Transcriptase Polymerase Chain Reactionbusiness.industryGeneral NeuroscienceProstatic Neoplasmsmedicine.diseaseHtert mrnamedicine.anatomical_structurebusinessQuantitative analysis (chemistry)Annals of the New York Academy of Sciences
researchProduct

hTERT mRNA expression in urine as a useful diagnostic tool in bladder cancer. Comparison with cytology and NMP22 BladderCheck Test®

2018

Abstract Introduction To study the relationship between quantitative mRNA determination (hTERT) in patients with bladder tumor, history of bladder tumor, and in subjects without a history of this neoplasia. Material and methods A prospective randomized controlled study with 91 subjects included. The value of mRNA-hTERTN was determined in 63 patients with a history or suspicion of bladder tumor and in 28 controls. Urine samples were sent for evaluation of the mRNA level (hTERT), the cytological study and the NMP22 result. Results Differences were observed in mean hTERTN levels in each of the groups: tumor presence 21.33 ± 40.66, tumor history 2.16 ± 2.67, controls 0.9 ± 1.75 (p  Conclusions …

medicine.medical_specialtyBladder cancermedicine.diagnostic_testbusiness.industryUrinary system030232 urology & nephrologyUrologyGeneral MedicineUrineCystoscopymedicine.diseaselaw.invention03 medical and health sciencesHtert mrna0302 clinical medicineRandomized controlled triallaw030220 oncology & carcinogenesisCytologymedicineTelomerase reverse transcriptasebusinessActas Urológicas Españolas (English Edition)
researchProduct